AbbVie (ABBV)
(Delayed Data from NYSE)
$168.59 USD
+2.03 (1.22%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $168.50 -0.09 (-0.05%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/25/24 |
---|---|
Current Quarter | 3.05 |
EPS Last Quarter | 2.31 |
Last EPS Surprise | 2.21% |
ABR | 1.76 |
Earnings ESP
|
-0.76% |
---|---|
Current Year | 11.26 |
Next Year | 12.08 |
EPS (TTM) | 10.96 |
P/E (F1) | 14.98 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 14.03B | 14.11B | 55.29B | 58.72B |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 14.11B | 14.27B | 55.84B | 60.43B |
Low Estimate | 13.97B | 13.97B | 54.96B | 57.18B |
Year ago Sales | 13.87B | 13.93B | 54.32B | 55.29B |
Year over Year Growth Est. | 1.18% | 1.33% | 1.79% | 6.19% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.05 | 2.88 | 11.26 | 12.08 |
# of Estimates | 11 | 9 | 12 | 11 |
Most Recent Consensus | 2.98 | 2.87 | 11.19 | 12.04 |
High Estimate | 3.11 | 2.93 | 11.40 | 12.71 |
Low Estimate | 2.98 | 2.82 | 11.13 | 11.74 |
Year ago EPS | 2.91 | 2.95 | 11.11 | 11.26 |
Year over Year Growth Est. | 4.81% | -2.37% | 1.35% | 7.32% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 9 | 2 | 9 | 6 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 7 | 1 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 3.05 | 2.88 | 11.26 | 12.08 |
7 Days Ago | 3.05 | 2.88 | 11.26 | 12.08 |
30 Days Ago | 3.06 | 2.88 | 11.27 | 12.08 |
60 Days Ago | 2.79 | 2.91 | 11.17 | 12.18 |
90 Days Ago | 2.79 | 2.90 | 11.17 | 12.20 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 3.03 | 2.88 | 11.16 | 12.20 |
Zacks Consensus Estimate | 3.05 | 2.88 | 11.26 | 12.08 |
Earnings ESP | -0.76% | 0.00% | -0.85% | 0.99% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.31 | 2.79 | 2.95 | 2.91 | NA |
Estimate | 2.26 | 2.76 | 2.86 | 2.79 | NA |
Difference | 0.05 | 0.03 | 0.09 | 0.12 | 0.07 |
Surprise | 2.21% | 1.09% | 3.15% | 4.30% | 2.69% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more